Olmark-AH Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Olmesartan Medoxomil (20mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Olmark-AH Tablet
Hyperten-Duo tablets combine medications to manage hypertension when monotherapy proves insufficient. This treatment lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Hyperten-Duo may be taken with or without food; dosage is individualized based on your response and condition. Consistent daily timing is recommended. Continue this medication as directed by your physician; discontinuation may increase stroke or heart attack risk. The formulation includes a diuretic, increasing urination; avoid dosing within four hours of bedtime. Regular use, even when feeling well, maximizes benefits, as hypertension often presents asymptomatically. Common side effects include ankle edema, headache, dizziness, fatigue, and altered taste. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counteract potential muscle weakness, dry mouth, or thirst. Prior to use, disclose any liver or kidney issues, and pregnant or breastfeeding individuals should seek medical counsel. Inform your doctor of all current medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, kidney function, electrolytes, and blood glucose levels is crucial to assess treatment effectiveness.
Primary Ingredients of Olmark-AH Tablet
No text provided to rephrase.
Uses of Olmark-AH Tablet
Elevated blood pressure
Major Benefits of Olmark-AH Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Olmark-AH Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
Common Side effects of Olmark-AH Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Olmark-AH Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or fracture it. Olmark-AH Tablets can be administered with or without food, although consistent timing is recommended.
How Olmark-AH Tablet works:
Olmark-AH Tablet unites three distinct medications: olmesartan medoxomil, amlodipine, and hydrochlorothiazide. Olmesartan medoxomil, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, synergistically dilate blood vessels, reducing blood pressure. Hydrochlorothiazide, a diuretic, promotes fluid and electrolyte excretion via the kidneys, contributing to vasodilation and enhanced circulation over time.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Olmark-AH Tablet should not be taken together.
PregnancyCONSULT YOUR DOCTOR
Using Olmark-AH Tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the inherent dangers. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Olmark-AH Tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Olmark-AH Tablet side effects. These side effects can include dizziness, headache, nausea, or fatigue, potentially impacting concentration and driving ability.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Olmark-AH Tablets, as dose modification may be necessary. A physician's consultation is advised. Olmark-AH Tablets are not recommended for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Olmark-AH Tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Olmark-AH Tablet :
Should you forget to take your Olmark-AH Tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmark-AH Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |






